Can I read Finerenone and Clinical Outcomes in CKD and Type 2.11 on EtoBox?

Finerenone and Clinical Outcomes in CKD and Type 2.11 by 19-088 samuel is a document available to read on EtoBox.

What is Finerenone and Clinical Outcomes in CKD and Type 2.11 about?

This post hoc analysis of the FIDELITY study found that finerenone significantly reduced the risk of kidney and cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes, regardless of their frailty status. The study involved 12,990 participants and demonstrated that higher frailty was associated with increased adverse outcomes, but finerenone was well tolerated across all frailty subgroups. Overall, finerenone effectively improved clinical outcomes without significant differ

Author

19-088 samuel

Language

EN